Identification and characterization of GLP-1 receptor–expressing cells using a new transgenic mouse model

Cited by (472)

Items 101–200 of 472

1. Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1
   Silvano Paternoster, Marco Falasca · 2018 · Frontiers in Endocrinology
2. Perspectives in GLP-1 Research: New Targets, New Receptors
   Giulia Cantini, Edoardo Mannucci, Michaela Luconi · 2016 · Trends in Endocrinology and Metabolism
3. Interactions between the microbiota and enteric nervous system during gut-brain disorders
   Steven G. Fried, Eve Wemelle, Patrice D. Cani, Claude Knauf · 2021 · Neuropharmacology
4. A novel mouse model of glucagon‐like peptide‐1 receptor expression: A look at the brain
   Devon L. Graham, Heather H. Durai, Taylor S. Trammell, Brenda L. Noble, Douglas P. Mortlock, Aurelio Galli, Gregg D. Stanwood · 2020 · The Journal of Comparative Neurology
5. The microbiota-gut-brain axis: Focus on the fundamental communication pathways
   Michela Bistoletti, Annalisa Bosi, Davide Banfi, Cristina Giaroni, Andreina Baj · 2020 · Progress in molecular biology and translational science
6. The gut–brain axis: Identifying new therapeutic approaches for type 2 diabetes, obesity, and related disorders
   Paul Richards, Nancy A. Thornberry, Shirly Pinto · 2021 · Molecular Metabolism
7. Glucagon-Like Peptide-1 (GLP-1) in the Integration of Neural and Endocrine Responses to Stress
   Diz-Chaves, Yolanda, Herrera-Pérez, Salvador, González-Matías, Lucas C., Lamas, José Antonio, Mallo, Federico · 2020 · Nutrients
8. Differential importance of endothelial and hematopoietic cell GLP-1Rs for cardiometabolic versus hepatic actions of semaglutide
   McLean, Brent A., Wong, Chi Kin, Kaur, Kiran Deep, Seeley, Randy J., Drucker, Daniel J. · 2021 · JCI Insight
9. Dulaglutide reduces binge episodes in type 2 diabetic patients with binge eating disorder: A pilot study
   Andrea Da Porto, Viviana Casarsa, GianLuca Colussi, Cristiana Catena, Alessandro Cavarape, Leonardo Antonio Sechi · 2020 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
10. Glucagon-Like Peptide-1 Excites Firing and Increases GABAergic Miniature Postsynaptic Currents (mPSCs) in Gonadotropin-Releasing Hormone (GnRH) Neurons of the Male Mice via Activation of Nitric Oxide (NO) and Suppression of Endocannabinoid Signaling Pathways
    Farkas, Imre, Vastagh, Csaba, Farkas, Erzsébet, Bálint, Flóra, Skrapits, Katalin, Hrabovszky, Erik, Fekete, Csaba, Liposits, Zsolt · 2016 · Frontiers in Cellular Neuroscience
11. The Ascending GLP-1 Road From Clinical Safety to Reduction of Cardiovascular Complications
    Daniel J. Drucker · 2018 · Diabetes
12. Glucagon-like peptide-1 (GLP-1) receptor activation dilates cerebral arterioles, increases cerebral blood flow, and mediates remote (pre)conditioning neuroprotection against ischaemic stroke
    Nizari, Shereen, Basalay, Marina, Chapman, Philippa, Korte, Nils, Korsak, Alla, Christie, Isabel N., Theparambil, Shefeeq M., Davidson, Sean M., Reimann, Frank, Trapp, Stefan et al. · 2021 · Basic Research in Cardiology
13. Liraglutide Reduces Postprandial Hyperlipidemia by Increasing ApoB48 (Apolipoprotein B48) Catabolism and by Reducing ApoB48 Production in Patients With Type 2 Diabetes Mellitus
    Vergès, Bruno, Duvillard, Laurence, Pais de Barros, Jean Paul, Bouillet, Benjamin, Baillot-Rudoni, Sabine, Rouland, Alexia, Sberna, Anne-Laure, Petit, Jean-Michel, Degrace, Pascal, Demizieux, Laurent · 2018 · Arteriosclerosis, Thrombosis, and Vascular Biology
14. Actions of glucagon‐like peptide‐1 receptor ligands in the gut
    Jens Juul Holst, Daniel Bjørklund Andersen, Kaare Villum Grunddal · 2021 · British Journal of Pharmacology
15. The Sensory Mechanisms of Nutrient-Induced GLP-1 Secretion
    Anna Pii Hjørne, Ida Marie Modvig, Jens Juul Holst · 2022 · Metabolites
16. The role of the vagus nerve in appetite control: Implications for the pathogenesis of obesity
    Simon C. Cork · 2018 · Journal of Neuroendocrinology
17. The GLP-1 Receptor Agonist Liraglutide Increases Myocardial Glucose Oxidation Rates via Indirect Mechanisms and Mitigates Experimental Diabetic Cardiomyopathy
    Malak Ghazi Almutairi, Keshav Gopal, Amanda A. Greenwell, Adrian Young, Robert Gill, Hanin Aburasayn, Rami Al Batran, Jadin J. Chahade, Manoj Gandhi, Farah Eaton et al. · 2020 · Canadian Journal of Cardiology
18. Role of Sirtuins in Modulating Neurodegeneration of the Enteric Nervous System and Central Nervous System
    Pavithra Chandramowlishwaran, Anitha Vijay, Daniel Abraham, Ge Li, Simon Musyoka Mwangi, Shanthi Srinivasan · 2020 · Frontiers in Neuroscience
19. Proglucagon-Derived Peptides as Therapeutics
    Ryan A. Lafferty, Finbarr P.M. O'Harte, Nigel Irwin, Victor A. Gault, Peter R. Flatt · 2021 · Frontiers in Endocrinology
20. The role of glia in the physiology and pharmacology of glucagon‐like peptide‐1: implications for obesity, diabetes, neurodegeneration and glaucoma
    Qi N. Cui, Lauren Michelle Stein, Samantha M. Fortin, Matthew R. Hayes · 2021 · British Journal of Pharmacology
21. GLP-1R–Targeting Magnetic Nanoparticles for Pancreatic Islet Imaging
    Ping Wang, Byunghee Yoo, Jingsheng Yang, Xueli Zhang, Alana Ross, Pamela Pantazopoulos, Guangping Dai, Anna V. Moore · 2014 · Diabetes
22. Exenatide exerts a PKA-dependent positive inotropic effect in human atrial myocardium
    Markus Wallner, Ewald Kolesnik, Klemens Ablasser, Mounir Khafaga, Paulina Wakula, Senka Ljubojević-Holzer, Eva Thon-Gutschi, Harald Sourij, Martin Kapl, Nicholas J. Edmunds et al. · 2015 · Journal of Molecular and Cellular Cardiology
23. Overcoming the challenges of tissue delivery for oligonucleotide therapeutics
    Tufan Gökirmak, Mehran Nikan, Svenja Wiechmann, Thazha P. Prakash, Michael Tanowitz, Punit P. Seth · 2021 · Trends in Pharmacological Sciences
24. Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
    Francesco Bifari, Roberto Manfrini, Michele Dei, Cesare Berra, Matteo Siano, Massimo Giovanni Zuin, Rita Clara Paroni, Franco B. Folli · 2018 · Pharmacological Research
25. Glucagon-Like Peptide-1 Receptor Agonism Improves Nephrotoxic Serum Nephritis by Inhibiting T-Cell Proliferation
    Moschovaki Filippidou, Foteini, Kirsch, Alexander H., Thelen, Matthias, Kétszeri, Máté, Artinger, Katharina, Aringer, Ida, Schabhüttl, Corinna, Mooslechner, Agnes A., Frauscher, Bianca, Pollheimer, Marion et al. · 2020 · The American Journal of Pathology
26. Our Mental Health Is Determined by an Intrinsic Interplay between the Central Nervous System, Enteric Nerves, and Gut Microbiota
    Leon M. T. Dicks · 2023 · International Journal of Molecular Sciences
27. Progesterone Receptor Membrane Component 1 Is a Functional Part of the Glucagon-like Peptide-1 (GLP-1) Receptor Complex in Pancreatic β Cells
    Ming Zhang, Mélanie Robitaille, Aaron D. Showalter, Xinyi Huang, Ying Liu, Alpana Bhattacharjee, Francis S. Willard, Junfeng Han, D. Sean Froese, Wei Li et al. · 2014 · Molecular & Cellular Proteomics
28. Pancreas Volume and Fat Deposition in Diabetes and Normal Physiology: Consideration of the Interplay Between Endocrine and Exocrine Pancreas
    Yoshifumi Saisho · 2016 · The Review of Diabetic Studies
29. Vascular Biology of Glucagon Receptor Superfamily Peptides: Mechanistic and Clinical Relevance
    Gemma Pujadas, Daniel J. Drucker · 2016 · Endocrine Reviews
30. Peptide‐based multi‐agonists: a new paradigm in metabolic pharmacology
    Sara J. Brandt, Timo D. Müller, Richard D. DiMarchi, M. Tschöp, Kerstin Stemmer · 2018 · Journal of Internal Medicine
31. Activation of AMPK by GLP-1R agonists mitigates Alzheimer-related phenotypes in transgenic mice
    Yun Zhang, Huaqiu Chen, Yijia Feng, Mingjing Liu, Zhi Lu, Bolang Hu, Lifen Chen, Yang Zhang, Jiawen Liu, Fang Cai et al. · 2025 · Nature Aging
32. Potential side effects to GLP-1 agonists: understanding their safety and tolerability
    Agostino Consoli, Gloria Formoso · 2014 · Expert Opinion on Drug Safety
33. G protein-coupled receptors as new therapeutic targets for type 2 diabetes
    Frank M. Reimann, Fiona Mary Gribble · 2015 · Diabetologia
34. Localization of Glucagon-Like Peptide-2 Receptor Expression in the Mouse
    Bernardo Yusta, Dianne Matthews, Jacqueline A. Koehler, Gemma Pujadas, Kiran Deep Kaur, Daniel J. Drucker · 2019 · Endocrinology
35. Glucagon-like peptide 1 and peptide YY are in separate storage organelles in enteroendocrine cells
    Hyun‐Jung Cho, Eliza S. Robinson, Leni R. Rivera, Paul J. McMillan, Adam Testro, Mehrdad Nikfarjam, David M. Bravo, John B. Furness · 2014 · Cell and Tissue Research
36. Glucagon-Like Peptide-1 Receptor Agonists Increase Pancreatic Mass by Induction of Protein Synthesis
    Jacqueline A. Koehler, Laurie L. Baggio, Xiemin Cao, Tahmid Abdulla, Jonathan Edward Campbell, Thomas Secher, Jacob Jelsing, Brett G. Larsen, Daniel J. Drucker · 2014 · Diabetes
37. Exendin-4 inhibits structural remodeling and improves Ca 2+ homeostasis in rats with heart failure via the GLP-1 receptor through the eNOS/cGMP/PKG pathway
    Jingjing Chen, Dandan Wang, Fangai Wang, Shaobo Shi, Yuting Chen, Bo Yang, Yanhong Tang, Congxin Huang · 2017 · Peptides
38. Absence of Glucagon and Insulin Action Reveals a Role for the GLP-1 Receptor in Endogenous Glucose Production
    Jun, Lucy S., Millican, Rohn L., Hawkins, Eric D., Konkol, Debra L., Showalter, Aaron D., Christe, Michael E., Michael, M. Dodson, Sloop, Kyle W. · 2015 · Diabetes
39. Microbial Modulation of the Development and Physiology of the Enteric Nervous System
    Amélie Joly, François Leulier, Filipe De Vadder · 2020 · Trends in Microbiology
40. Hypothalamic GLP-1: the control of BAT thermogenesis and browning of white fat
    Miguel López, Carlos Diéguez, Rubén Nogueiras · 2014 · Adipocyte
41. Neuropods
    Rodger A. Liddle · 2019 · Cellular and Molecular Gastroenterology and Hepatology
42. Cross-Species Comparison of Genes Related to Nutrient Sensing Mechanisms Expressed along the Intestine
    Nikkie van der Wielen, Mark H. P. van Avesaat, Nicole J. W. de Wit, Jack Vogels, Freddy J. Troost, Ad Masclee, S.J. Koopmans, Jan van der Meulen, Mark V. Boekschoten, Michael M. Müller et al. · 2014 · PLoS ONE
43. The gut microbiota to the brain axis in the metabolic control
    Estelle Grasset, Rémy Burcelin · 2019 · Reviews in Endocrine and Metabolic Disorders
44. Incretins
    Tongzhi Wu, Christopher Keith Rayner, Michael Horowitz · 2015 · Handbook of experimental pharmacology
45. GLP-1 receptor signaling increases PCSK1 and β cell features in human α cells
    Mridusmita Saikia, Marlena M. Holter, Leanne R. Donahue, Isaac S. Lee, Qiaonan C. Zheng, Journey L. Wise, Jenna E. Todero, Daryl J. Phuong, Darline Garibay, Reilly W. Coch et al. · 2021 · JCI Insight
46. Targeting systemic inflammation in metabolic disorders. A therapeutic candidate for the prevention of cardiovascular diseases?
    Elena Domingo, Patrice Marqués, Vera Francisco, Laura Piqueras, María‐Jesús Sanz · 2024 · Pharmacological Research
47. Glucoregulatory Relevance of Small Intestinal Nutrient Sensing in Physiology, Bariatric Surgery, and Pharmacology
    Frank Anthony Duca, Paige V. Bauer, Sophie C. Hamr, Tony K.T. Lam · 2015 · Cell Metabolism
48. The incretin hormone glucagon‐like peptide 1 increases mitral cell excitability by decreasing conductance of a voltage‐dependent potassium channel
    Nicolas Thiebaud, Ida J. Llewellyn‐Smith, Fiona Mary Gribble, Frank M. Reimann, Stefan Trapp, Debra Ann Fadool · 2016 · The Journal of Physiology
49. Glucosensing in the gastrointestinal tract: Impact on glucose metabolism
    Audren Fournel, Alysson Marlin, Anne Abot, Charles Pasquio, Carla Cirillo, Patrice D. Cani, Claude Knauf · 2016 · American Journal of Physiology-Gastrointestinal and Liver Physiology
50. Using a Reporter Mouse to Map Known and Novel Sites of GLP-1 Receptor Expression in Peripheral Tissues of Male Mice
    Andersen, Daniel B, Grunddal, Kaare V, Pedersen, Jens, Kuhre, Rune E, Lund, Mari L, Holst, Jens J, Ørskov, Cathrine · 2021 · Endocrinology
51. GLP-1 action in the mouse bed nucleus of the stria terminalis
    Diana L. Williams, Nicole Lilly, Ian James Edwards, Pallas Yao, James E. Richards, Stefan Trapp · 2017 · Neuropharmacology
52. Activation of Short and Long Chain Fatty Acid Sensing Machinery in the Ileum Lowers Glucose Production in Vivo
    Melika Zadeh‐Tahmasebi, Frank Anthony Duca, Brittany A. Rasmussen, Paige V. Bauer, Clémence D. Côté, B Filippi, Tony K.T. Lam · 2016 · Journal of Biological Chemistry
53. Adenosine triphosphate is co-secreted with glucagon-like peptide-1 to modulate intestinal enterocytes and afferent neurons
    Van B. Lu, Juraj Rievaj, Elisabeth A. A. O’Flaherty, Christopher A. Smith, Ramona Pais, Luke A. Pattison, Gwen Tolhurst, Andrew B. Leiter, David Colin Bulmer, Fiona Mary Gribble et al. · 2019 · Nature Communications
54. A Comparison of the Effects of the GLP-1 Analogue Liraglutide and Insulin Glargine on Endothelial Function and Metabolic Parameters: A Randomized, Controlled Trial Sapporo Athero-Incretin Study 2 (SAIS2)
    Hiroshi Nomoto, Hideaki Miyoshi, Tomoo Furumoto, Koji Oba, Hiroyuki Tsutsui, Arina Miyoshi, Takuma Kondo, Kenichi Tsuchida, Tatsuya Atsumi, Naoki Manda et al. · 2015 · PLoS ONE
55. Brain GLP-1 and insulin sensitivity
    Darleen A. Sandoval, Stephanie R. Sisley · 2015 · Molecular and Cellular Endocrinology
56. Involvement of gut microbiota in association between GLP-1/GLP-1 receptor expression and gastrointestinal motility
    Mo Yang, Hirokazu Fukui, Hirotsugu Eda, Xin Juan Xu, Yoshitaka Kitayama, Ken Hara, Mio Kodani, Toshihiko Tomita, Tadayuki Oshima, Jiro Watari et al. · 2017 · American Journal of Physiology-Gastrointestinal and Liver Physiology
57. Molecular imaging of β-cells: diabetes and beyond
    Weijun Wei, Emily B. Ehlerding, Xiaoli Lan, Quan‐Yong Luo, Weibo Cai · 2018 · Advanced Drug Delivery Reviews
58. GLP-1 receptor agonist-based therapies and cardiovascular risk: a review of mechanisms
    Mullur, Neerav, Morissette, Arianne, Morrow, Nadya M, Mulvihill, Erin E · 2024 · Journal of Endocrinology
59. Glucagon-Like Peptide 1 Analogs and their Effects on Pancreatic Islets
    Eva Tudurí, Miguel López, Carlos Diéguez, Ángel Nadal, Rubén Nogueiras · 2016 · Trends in Endocrinology and Metabolism
60. Brain Endothelial Cells Regulate Glucagon-Like Peptide 1 Entry Into the Brain via a Receptor-Mediated Process
    Zhuo Fu, Liying Gong, Jia Liu, Jing Wu, Eugene J. Barrett, Kevin W. Aylor, Zhenqi Liu · 2020 · Frontiers in Physiology
61. Cardiorenal mechanisms of action of glucagon-like-peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors
    David Z.I. Cherney, Jacob Allen Udell, Daniel J. Drucker · 2021 · Med
62. Biased agonism and polymorphic variation at the GLP-1 receptor: Implications for the development of personalised therapeutics
    Liliane El Eid, Christopher Arthur Reynolds, Alejandra Tomás, Ben J. Jones · 2022 · Pharmacological Research
63. GLP-1 Elicits an Intrinsic Gut–Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance
    Rituraj Khound, Jennifer Taher, Christopher Baker, Khosrow Adeli, Qiaozhu Su · 2017 · Arteriosclerosis Thrombosis and Vascular Biology
64. Tryptophan and Its Metabolite Serotonin Impact Metabolic and Mental Disorders via the Brain–Gut–Microbiome Axis: A Focus on Sex Differences
    M. Xu, Ethan Y. Zhou, Haifei Shi · 2025 · Cells
65. Molecular and cellular mechanisms of glucagon-like peptide-1 receptor agonist-mediated attenuation of cardiac fibrosis
    Tracey A. Gaspari, Melita Brdar, Huey Wen Lee, Iresha Spizzo, Yunshan Hu, Robert E. Widdop, Richard W Simpson, Anthony E. Dear · 2015 · Diabetes and Vascular Disease Research
66. GLP-1R–positive neurons in the lateral septum mediate the anorectic and weight-lowering effects of liraglutide in mice
    Chen, Zijun, Deng, Xiaofei, Shi, Cuijie, Jing, Haiyang, Tian, Yu, Zhong, Jiafeng, Chen, Gaowei, Xu, Yunlong, Luo, Yixiao, Zhu, Yingjie · 2024 · Journal of Clinical Investigation
67. Antidiabetic Agents and Endothelial Dysfunction – Beyond Glucose Control
    Linnéa Eriksson, Thomas Nyström · 2015 · Basic & Clinical Pharmacology & Toxicology
68. Exogenous glucagon-like peptide 1 reduces contractions in human colon circular muscle
    Antonella Amato, Sara Baldassano, Rosa Liotta, Rosa Serio, Flavia Mulè · 2014 · Journal of Endocrinology
69. Glucagon-like peptide-1 receptor is present in pancreatic acinar cells and regulates amylase secretion through cAMP
    Yanan Hou, Stephen A. Ernst, Kaeli Heidenreich, John A. Williams · 2015 · American Journal of Physiology-Gastrointestinal and Liver Physiology
70. Central Nervous System GLP-1 Receptors Regulate Islet Hormone Secretion and Glucose Homeostasis in Male Rats
    Lene Jessen, Eric P. Smith, Yvonne M. Ulrich‐Lai, James P. Herman, Randy J. Seeley, Darleen A. Sandoval, David A. D’Alessio · 2017 · Endocrinology
71. Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury
    Elliot J. Glotfelty, Thomas Delgado, Luis B. Tovar‐y‐Romo, Yu Luo, Barry J. Hoffer, Lars Olson, Tobias E. Karlsson, Mark P. Mattson, Brandon K. Harvey, David Tweedie et al. · 2019 · ACS Pharmacology & Translational Science
72. Targeting the Enteric Nervous System to Treat Metabolic Disorders? “Enterosynes” as Therapeutic Gut Factors
    Claude Knauf, Anne Abot, Eve Wemelle, Patrice D. Cani · 2019 · Neuroendocrinology
73. A comparative transcriptomic analysis of glucagon-like peptide-1 receptor- and glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamus
    Christopher Smith, Ryan Patterson-Cross, Orla R. M. Woodward, Jo Edward Lewis, Davide Chiarugi, Florian T. Merkle, Fiona Mary Gribble, Frank M. Reimann, Alice E. Adriaenssens · 2022 · Appetite
74. Cardiovascular Benefits of Native GLP-1 and its Metabolites: An Indicator for GLP-1-Therapy Strategies
    Junfeng Li, Juan Zheng, Susanne Wang, Harry Lau, Ali Fathi, Qinghua Wang · 2017 · Frontiers in Physiology
75. The metabolite GLP‐1 (9‐36) is neuroprotective and anti‐inflammatory in cellular models of neurodegeneration
    Yazhou Li, Elliot J. Glotfelty, Tobias E. Karlsson, Lowella V. Fortuno, Brandon K. Harvey, Nigel H. Greig · 2021 · Journal of Neurochemistry
76. The role of gut endocrine cells in control of metabolism and appetite
    Helen E. Parker, Fiona Mary Gribble, Frank M. Reimann · 2014 · Experimental Physiology
77. The endogenous preproglucagon system is not essential for gut growth homeostasis in mice
    Pernille Wismann, Pernille Barkholt, Thomas Secher, Niels Vrang, Henrik Bo Hansen, Palle Bekker Jeppesen, Laurie L. Baggio, Jacqueline A. Koehler, Daniel J. Drucker, Darleen A. Sandoval et al. · 2017 · Molecular Metabolism
78. Ligand-Specific Factors Influencing GLP-1 Receptor Post-Endocytic Trafficking and Degradation in Pancreatic Beta Cells
    Zijian Fang, Shiqian Chen, Yusman Manchanda, Stavroula Bitsi, Philip Pickford, Alessia David, Maria M. Shchepinova, Ivan Reis Correa Junior, David J. Hodson, Johannes Broichhagen et al. · 2020 · International Journal of Molecular Sciences
79. Therapeutic Potential of a Novel Glucagon-like Peptide-1 Receptor Agonist, NLY01, in Experimental Autoimmune Encephalomyelitis
    Marjan Gharagozloo, Matthew D. Smith, Elias S. Sotirchos, Jing Jin, Keya R Meyers, Michelle Taylor, Thomas P. Garton, Riley N. Bannon, Hannah‐Noelle Lord, Ted M. Dawson et al. · 2021 · Neurotherapeutics
80. DPP (Dipeptidyl Peptidase)-4 Inhibitor Attenuates Ang II (Angiotensin II)–Induced Cardiac Hypertrophy via GLP (Glucagon-Like Peptide)-1–Dependent Suppression of Nox (Nicotinamide Adenine Dinucleotide Phosphate Oxidase) 4-HDAC (Histone Deacetylase) 4 Pathway
    Kosuke Okabe, Shouji Matsushima, Soichiro Ikeda, Masataka Ikeda, Akihito Ishikita, Tomonori Tadokoro, Nobuyuki Enzan, Taishi Yamamoto, Masashi Sada, Hiroko Deguchi et al. · 2020 · Hypertension
81. Apple Polyphenols Extracts Ameliorate High Carbohydrate Diet-Induced Body Weight Gain by Regulating the Gut Microbiota and Appetite
    Xinjing Wang, Fang Liu, Yuan Cui, Yan Yin, Shilan Li, Xinli Li · 2021 · Journal of Agricultural and Food Chemistry
82. Semaglutide inhibits ischemia/reperfusion-induced cardiomyocyte apoptosis through activating PKG/PKCε/ERK1/2 pathway
    Qiuxia Zhu, Yong Luo, Yuetao Wen, Ding Wang, Jing Li, Zhongcai Fan · 2023 · Biochemical and Biophysical Research Communications
83. Rewiring the Brain Through the Gut: Insights into Microbiota–Nervous System Interactions
    Ilinca Săvulescu-Fiedler, Serban Nicolae Benea, Constantin Căruntu, Andreea-Simona Nancoff, Corina Homentcovschi, Săndica Bucurica · 2025 · Current Issues in Molecular Biology
84. After the LEADER trial and SUSTAIN-6, how do we explain the cardiovascular benefits of some GLP-1 receptor agonists?
    Bruno L Vergès, Bernard H. Charbonnel · 2017 · Diabetes & Metabolism
85. Metabolic responses and benefits of glucagon‐like peptide‐1 (GLP‐1) receptor ligands
    Neil Tanday, Peter R. Flatt, Nigel Irwin · 2021 · British Journal of Pharmacology
86. Plaque-targeted, proteolysis-resistant, activatable and MRI-visible nano-GLP-1 receptor agonist targets smooth muscle cell differentiation in atherosclerosis
    Andrei Maiseyeu, Lin Di, Anastasia M. Ravodina, Alma Rosa Barajas‐Espinosa, Atsushi Sakamoto, Alice Mary Lillian Chaplin, Jixin Zhong, Huiyun Gao, Matthew Mignery, Navneet Narula et al. · 2022 · Theranostics
87. Discordance between GLP-1R gene and protein expression in mouse pancreatic islet cells
    Sarah M. Gray, Yurong Xin, Elizabeth C. Ross, Bryanna M. Chazotte, Megan E. Capozzi, KIMBERLEY M. EL, Berit Svendsen, Peter Ravn, Kyle W. Sloop, Jenny Tong et al. · 2020 · Journal of Biological Chemistry
88. <scp>GLP</scp>‐1 and insulin regulation of skeletal and cardiac muscle microvascular perfusion in type 2 diabetes
    Love, Kaitlin M., Liu, Jia, Regensteiner, Judith G., Reusch, Jane E.B., Liu, Zhenqi · 2020 · Journal of Diabetes
89. Reagents and models for detecting endogenous GLP1R and GIPR
    Ast, Julia, Broichhagen, Johannes, Hodson, David J. · 2021 · EBioMedicine
90. Effect of the Glucagon-Like Peptide-1 Receptor Agonists on Autonomic Function in Subjects with Diabetes: A Systematic Review and Meta-Analysis
    Carla Greco, Daniele Santi, Giulia Brigante, Chiara Pacchioni, Manuela Simoni · 2022 · Diabetes & Metabolism Journal
91. Emerging Roles of Small GTPases in Islet β-Cell Function
    Rajakrishnan Veluthakal, Debbie C. Thurmond · 2021 · Cells
92. GLP1R and GIPR expression and signaling in pancreatic alpha cells, beta cells and delta cells
    Shilleh, Ali H., Viloria, Katrina, Broichhagen, Johannes, Campbell, Jonathan E., Hodson, David J. · 2024 · Peptides
93. Gut-brain mechanisms controlling glucose homeostasis
    Jarrad M. Scarlett, Michael W. Schwartz · 2015 · F1000Prime Reports
94. Synergistic effects of metformin with liraglutide against endothelial dysfunction through GLP-1 receptor and PKA signalling pathway
    Jing Ke, Ye Liu, Jin Yang, Ran Lu, Qing Tian, Wenfang Hou, Guang Wang, Rui Wei, Tianpei Hong · 2017 · Scientific Reports
95. Glucose stimulates somatostatin secretion in pancreatic δ-cells by cAMP-dependent intracellular Ca2+ release
    Geoffrey Denwood, Andrei I. Tarasov, Albert A. Salehi, Elisa Vergari, Reshma D. Ramracheya, Harumi Takahashi, Viacheslav O. Nikolaev, Susumo Seino, Fiona Mary Gribble, Frank M. Reimann et al. · 2019 · The Journal of General Physiology
96. Advances in GLP-1 receptor targeting radiolabeled agent development and prospective of theranostics
    Irina Velikyan, Olof Eriksson · 2019 · Theranostics
97. Incretin combination therapy for the treatment of non-alcoholic steatohepatitis
    Kannt, Aimo, Madsen, Andreas Nygaard, Kammermeier, Claire, Elvert, Ralf, Klöckener, Tim, Bossart, Martin, Haack, Torsten, Evers, Andreas, Lorenz, Katrin, Hennerici, Wolfgang et al. · 2020 · Diabetes, Obesity and Metabolism
98. Pancreatic β‐cell imaging in humans: fiction or option?
    Didier Laurent, Laurent Vinet, Smaragda Lamprianou, Marie Daval, Gaëlle Filhoulaud, Alain Ktorza, H. Wang, Sabine Sewing, H. P. Juretschke, Heiner Glombik et al. · 2015 · Diabetes Obesity and Metabolism
99. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction
    Quan Qi, Lei Lu, Haiqing Li, Zhize Yuan, Gaoxian Chen, Miao Lin, Zhengwen Ruan, Xiaofeng Ye, Zeyu Xiao, Qiang Zhao · 2017 · International Journal of Nanomedicine
100. Development and characterisation of a novel glucagon like peptide-1 receptor antibody
     Emma K. Biggs, Lihuan Liang, Jacqueline Naylor, Shimona Madalli, Rachel Collier, Matthew P. Coghlan, David J. Baker, David C. Hornigold, Peter Ravn, Frank M. Reimann et al. · 2017 · Diabetologia